Wielsbeke, Belgium, March 14, 2006 – The Unilin group and the Egger group have announced that they have entered into a more detailed license agreement for certain glueless flooring systems. The ...

SHANGHAI, Sept. 24, 2025 /PRNewswire/ -- Hengrui Pharma (600276.SH; 01276.HK), a leading innovative global pharmaceutical company focused on scientific and technological innovation, announced today ...

Cree LED, a Penguin Solutions brand (Nasdaq: PENG), and ADJ Products, LLC (ADJ) today announced that they have reached a mutually beneficial settlement resolving a patent infringement dispute ...

I agree with much of Ben Sasse’s provocative op-ed “University Trustees Have Their Heads in the Sand” (Sept. 11). He’s correct that campuses yearn for ideological variety, and that most professors don ...

Equally important, but often overlooked, is the question of a valid license (get a new Windows 11 license for 50% off on the PCWorld Software store): Don’t worry, in most cases, the upgrade from 10 to ...

- Upon closing, Arrowhead will receive an upfront payment of $200 million - Novartis will receive an exclusive worldwide license to ARO-SNCA, Arrowhead’s preclinical stage siRNA therapy for the ...

Vyriad, Inc., a clinical-stage biotechnology company developing targeted genetic therapies for cancer and other serious diseases, and Yeda Research and Development Company, Ltd., the commercial arm of ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced a global licensing and collaboration agreement with Novartis for ARO-SNCA, Arrowhead’s preclinical stage siRNA therapy against ...

I recently replaced motherboard and processor and reinstalled Windows 10 LTSC 2021 fully updated. I installed AdGuard-setup.8.0.5108.0.exe version which you sent me earlier when I reported slowdown, ...

When you buy through affiliate links in our content, we may earn a commission at no extra cost to you. Learn how our funding model works. By using this website you agree to our terms and conditions ...

Collaboration focuses on developing a KRAS G12D inhibitor, complementing Bayer's precision oncology development portfolio in the areas of pancreatic, colorectal and lung cancer KRAS mutations occur in ...